Using breast cancer cell CXCR4 surface expression to predict liposome binding and cytotoxicity
about
Use of Targeted Liposome-based Chemotherapeutics to Treat Breast CancerSelecting Targets for Tumor Imaging: An Overview of Cancer-Associated Membrane ProteinsOverexpression of CXCR4 is significantly associated with cisplatin-based chemotherapy resistance and can be a prognostic factor in epithelial ovarian cancer.ICAM-1 as a molecular target for triple negative breast cancerICAM-1-Targeted, Lcn2 siRNA-Encapsulating Liposomes are Potent Anti-angiogenic Agents for Triple Negative Breast CancerLiposomes coated with N-trimethyl chitosan to improve the absorption of harmine in vivo and in vitro.An engineered bivalent neuregulin protects against doxorubicin-induced cardiotoxicity with reduced proneoplastic potential.Inhibiting metastatic breast cancer cell migration via the synergy of targeted, pH-triggered siRNA delivery and chemokine axis blockadeIncorporating gold nanoclusters and target-directed liposomes as a synergistic amplified colorimetric sensor for HER2-positive breast cancer cell detectionPotential of CXCR4/CXCL12 Chemokine Axis in Cancer Drug Delivery.A drug-delivery vehicle combining the targeting and thermal ablation of HER2+ breast-cancer cells with triggered drug release.Albumin-fatty acid interactions at monolayer interface.CXCR4-antagonist Peptide R-liposomes for combined therapy against lung metastasis.A quantitative method for screening and identifying molecular targets for nanomedicine.Nanoparticle elasticity directs tumor uptake.Characterization of dormant and active human cancer cells by quantitative phase imaging.Peptide density targets and impedes triple negative breast cancer metastasis.
P2860
Q26797230-E91E8C36-F3B6-4597-AA95-182C9072A65DQ28077999-9A920EFF-6545-44FD-8CA6-E42CAED1DAEEQ34179827-BCA28266-72F3-4F53-BBF7-B0CE60FC2D46Q34383956-C39994B3-CA96-4B22-A351-D2B6139095EFQ36372319-87199ECE-D12C-443C-A0FC-C0DA4881A48BQ36498718-9A954F79-B1CB-4CE7-A813-179D8295CB34Q37121891-99EA961D-AE60-48D4-8B2D-E6CAB2BE5991Q37714248-43107275-102F-469B-A0F0-F5A2B6BF2A57Q37738222-5A594DC9-3992-442B-A585-AEB17518193FQ38810713-7E406AC2-4578-4FD4-AEC4-8B08CCA9F8BEQ39180899-DB7F87DF-0723-47E4-A17D-F8CEF02E075AQ39847358-E53495EC-FE85-46D8-BAD4-662C7A3C713DQ45293948-0948D77F-F3A2-4BE7-BB41-F1C377377D4EQ47315180-6A434FF5-4795-4988-9729-BEC773B1DA14Q48044023-8EF97B6E-202E-4425-8FEC-B98FC4CB77F7Q48681495-DE0FC486-E361-4166-9320-0BD25F26BADEQ55503101-4D186DC8-D854-4EE3-898E-F6778A47B8A6
P2860
Using breast cancer cell CXCR4 surface expression to predict liposome binding and cytotoxicity
description
2012 nî lūn-bûn
@nan
2012年の論文
@ja
2012年学术文章
@wuu
2012年学术文章
@zh-cn
2012年学术文章
@zh-hans
2012年学术文章
@zh-my
2012年学术文章
@zh-sg
2012年學術文章
@yue
2012年學術文章
@zh
2012年學術文章
@zh-hant
name
Using breast cancer cell CXCR4 ...... osome binding and cytotoxicity
@ast
Using breast cancer cell CXCR4 ...... osome binding and cytotoxicity
@en
type
label
Using breast cancer cell CXCR4 ...... osome binding and cytotoxicity
@ast
Using breast cancer cell CXCR4 ...... osome binding and cytotoxicity
@en
prefLabel
Using breast cancer cell CXCR4 ...... osome binding and cytotoxicity
@ast
Using breast cancer cell CXCR4 ...... osome binding and cytotoxicity
@en
P2093
P2860
P1433
P1476
Using breast cancer cell CXCR4 ...... osome binding and cytotoxicity
@en
P2093
Debra T Auguste
Jiang Yang
Jin-Oh You
Marsha A Moses
P2860
P304
P356
10.1016/J.BIOMATERIALS.2012.07.043
P50
P577
2012-08-09T00:00:00Z